Planchard D - Search Results

1

Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations.

Riudavets M, Sullivan I, Abdayem P, Planchard D. Riudavets M, et al. Among authors: planchard d. ESMO Open. 2021 Oct;6(5):100260. doi: 10.1016/j.esmoop.2021.100260. Epub 2021 Aug 31. ESMO Open. 2021. PMID: 34479034 Free PMC article. Review.

2

Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.

Planchard D, Bourgeois H, Adoun M, Paitel JF, Blanc P, Genet D, Ferru A, Meurice JC, Deletage C, Tourani JM. Planchard D, et al. Am J Clin Oncol. 2006 Aug;29(4):345-51. doi: 10.1097/01.coc.0000221320.81753.a9. Am J Clin Oncol. 2006. PMID: 16891860 Clinical Trial.

3

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC. Italiano A, et al. Among authors: planchard d. Bull Cancer. 2007;94(7 Suppl):F177-88. Bull Cancer. 2007. PMID: 17964994 Review. French.

4

[Angiogenesis targeting in lung cancers].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2007;94(7 Suppl):F217-22. Bull Cancer. 2007. PMID: 17964999 Review. French.

5

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 Free article. French.

6

[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value].

Planchard D, Loriot Y, Besse B. Planchard D, et al. Bull Cancer. 2009 Dec;96 Suppl:S57-68. doi: 10.1684/bdc.2009.0997. Bull Cancer. 2009. PMID: 20034871 French.

7

[ERCC1 and lung cancer].

Planchard D, Olaussen KA, Soria JC. Planchard D, et al. Rev Mal Respir. 2010 Apr;27(4):387-94. doi: 10.1016/j.rmr.2010.03.003. Epub 2010 Mar 25. Rev Mal Respir. 2010. PMID: 20403548 Review. French.

8

[DNA repair pathways and non-small cell lung cancer: clinical perspectives].

Olaussen KA, Planchard D, Adam J, Soria JC. Olaussen KA, et al. Among authors: planchard d. Bull Cancer. 2011 Mar;98(3):305-22. doi: 10.1684/bdc.2011.1327. Bull Cancer. 2011. PMID: 21459711 Free article. Review. French.

9

[Biomarkers and targeted therapies in non-small cell lung cancer: present and future treatments].

Planchard D, Giroux Leprieur E. Planchard D, et al. Rev Pneumol Clin. 2011 Jun;67 Suppl 1:S36-40. doi: 10.1016/S0761-8417(11)70009-8. Rev Pneumol Clin. 2011. PMID: 21777766 French.

10

Bevacizumab in non-small-cell lung cancer: a review.

Planchard D. Planchard D. Expert Rev Anticancer Ther. 2011 Aug;11(8):1163-79. doi: 10.1586/era.11.80. Expert Rev Anticancer Ther. 2011. PMID: 21916570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page